Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis

ClinicalTrials.gov ID: NCT00137371

Public ClinicalTrials.gov record NCT00137371. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 27, 2026, 7:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women With Atrophic Vaginitis

Study identification

NCT ID: NCT00137371
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Enrollment: 480 participants

Conditions and interventions

Conditions

Interventions

PVC (daily for 21 days, 7 days off) Drug
PVC (twice weekly) Drug

Drug

Eligibility (public fields only)

Age range: 45 Years to 80 Years
Sex: Female
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2005
Primary completion: Not listed
Completion: Aug 31, 2007
Last update posted: Dec 9, 2007

2005 – 2007

United States locations

U.S. sites: 32
U.S. states: 16
U.S. cities: 31

Facility	City	State	ZIP	Site status
Not listed	Tucson	Arizona	85715	—
Not listed	Encinitas	California	92024	—
Not listed	San Diego	California	92108	—
Not listed	Torrance	California	90502	—
Not listed	Aurora	Colorado	80010	—
Not listed	Brooksville	Florida	34613	—
Not listed	Miami	Florida	33186	—
Not listed	St. Petersburg	Florida	33709	—
Not listed	Tampa	Florida	33066	—
Not listed	West Palm Beach	Florida	33407	—
Not listed	Atlanta	Georgia	30328	—
Not listed	Augusta	Georgia	30901	—
Not listed	Chicago	Illinois	60612	—
Not listed	Metairie	Louisiana	70006	—
Not listed	Troy	Michigan	48084	—
Not listed	St Louis	Missouri	63141	—
Not listed	Omaha	Nebraska	68134	—
Not listed	New Brunswick	New Jersey	08901	—
Not listed	Chapel Hill	North Carolina	27514	—
Not listed	Winston-Salem	North Carolina	27103	—
Not listed	Oklahoma City	Oklahoma	73112	—
Not listed	Danville	Pennsylvania	17822-2920	—
Not listed	Philadelphia	Pennsylvania	19104	—
Not listed	Pittsburgh	Pennsylvania	15206	—
Not listed	Carrollton	Texas	75006	—
Not listed	Carrollton	Texas	75010	—
Not listed	Colleyville	Texas	76034	—
Not listed	Dallas	Texas	75246	—
Not listed	Houston	Texas	77030	—
Not listed	Plano	Texas	75093	—
Not listed	Charlottesville	Virginia	22903	—
Not listed	Norfolk	Virginia	23502	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00137371, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 9, 2007 · Synced Apr 27, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00137371 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →